Medtronic (MDT) analyst forecast and price target
Analyst forecast
Consensus of 30 analyst ratings
Based on 11 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $99.00 from $100.00 | Oct 12, 2026 |
| Barclays | Initiated Coverage | Equal-Weight | $95.00 | Oct 7, 2026 |
| TD Cowen | Maintained | Buy | $110.00 | Sep 30, 2026 |
| UBS | Maintained | Buy | $110.00 from $100.00 | Sep 3, 2026 |
| Baird | Maintained | Neutral | $100.00 from $91.00 | Sep 2, 2026 |
| Stifel | Maintained | Hold | $95.00 from $80.00 | Sep 2, 2026 |
| B of A Securities | Maintained | Buy | $110.00 from $95.00 | Sep 2, 2026 |
| RBC Capital | Maintained | Outperform | $118.00 | Sep 2, 2026 |
| Wells Fargo | Maintained | Overweight | $104.00 from $102.00 | Sep 2, 2026 |
| Truist Securities | Maintained | Hold | $99.00 from $86.00 | Sep 2, 2026 |
| BTIG | Maintained | Buy | $100.00 from $91.00 | Sep 1, 2026 |
| Needham | Maintained | Buy | $114.00 | Sep 1, 2026 |
| TD Cowen | Maintained | Buy | $110.00 from $100.00 | Aug 28, 2026 |
| Needham | Maintained | Buy | $114.00 from $101.00 | Aug 27, 2026 |
| BTIG | Maintained | Buy | $91.00 | Aug 18, 2026 |
| UBS | Upgraded | Neutral → Buy | $100.00 from $85.00 | Jul 28, 2026 |
| TD Cowen | Maintained | Buy | $100.00 from $119.00 | Jul 10, 2026 |
| Evercore ISI Group | Maintained | Outperform | $105.00 from $106.00 | Jul 6, 2026 |
| Needham | Maintained | Buy | $101.00 | Jun 17, 2026 |
| Bernstein | Maintained | Outperform | $97.00 from $112.00 | Jun 5, 2026 |
Frequently asked questions
What is the price target for MDT stock?
The average 12-month analyst price target for Medtronic (MDT) is $104.91, with a high estimate of $118.00 and a low of $95.00, across 11 analysts.
Is MDT a buy, sell, or hold?
Analysts covering Medtronic currently average a Buy rating: 19 buy, 11 hold and 0 sell, from 30 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for MDT?
The average price target of $104.91 implies 11.33% upside from the last price of $94.23.
What is the latest analyst rating on MDT?
On Oct 12, 2026, BTIG maintained Medtronic at Buy with a price target of $99.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.